Disk diffusion test and gradient methodologies

Antimicrobial Susceptibility Testing Protocols

Volumn , Issue , 2007, Pages 53-73

  Wanger, Audrey ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85123425073     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (37)

1. Foster, J.W. and Woodruff, M.B. Microbiological aspects of penicillin; methods of assay, J. Bacterio!., 46, 187-202, 1943.
2. Abraham, E.P., Chain, E., Fletcher, C.M., Florey, H.W., Gardner, A.D., Heatley, N.G., and Jennings, M.A. Further observations on penicillin, Lancet, ii, 177-188, 1941.
3. Bauer, A., Roberts, E., and Kirby, W.M.M. Single Disc Versus Multiple Disc and Plate Dilution Techniques for Antibiotic Sensitivity Testing, Vol. 1960, Department of Medicine, University of Washington School of Medicine and King County Hospital, Seattle, Washington, 1959.
4. Ericsson, H., Hogman, K., and Wickman, K. A paper disk method for determination of bacterial sensitivity to chemotherapeutic and antibiotic agents, Scand. J. Clin. Lab. Invest., 6, 21, 1954.
5. Ericsson, H., Shems, T., Antibiotic Sensitivity Testing Report of an International Collaborative Study (ICS), Ada Pathologica el Microbiologica Scandinavica, 1971.
6. Cooper, K.E. and Woodman, D. The diffusion of antiseptics through agar gels with special reference to the agar cup assay method of estimating the activity of penicillin, J. Pathol. Bacteriol., 58, 75-84, 1946.
7. Acar, J. and Goldstein, F.W. Disk susceptibility test, in Antibiotics in Laboratory Medicine, Lorian, V., Ed.,. Williams & Wilkins, Baltimore, 1996, 1-51.
8. Jorgensen, J., Turnidge, J., and Washington, J. Antibacterial susceptibility tests: Dilution and disk diffusion methods, in Manual of Clinical Microbiology, Murray, P.R., Ed., ASM Press, Washington DC, 1999, 1526-1543.
9. Bauer, A., Kirby, W.M.M., Sherris, J.C., and Turch, M. Antibiotic susceptibility testing by a standardized single disk method, Am. J. Clin. Pathol., 45, 493-496, 1966.
10. Stokes, E., and Ridgeway, G.L. Antibiotic sensitivity tests, in Clinical Microbiology, 6th ed., Edward Arnold, London, 1987, 204-221.
11. Finch, R.G. The clinical evaluation of antibacterial drugs: Guidelines of the British Society for Antimicrobial Chemotherapy, Eur. J. Clin. Microbiol. Infect. Dis., 9, 542-547, 1990.
12. Ericsson, H., Rational use of antibiotics in hospitals, Ph.D. thesis, Scand. J. Clin. Lab. Invest., 12, 414-422, 1960.
13. Craig, W. Qualitative Susceptibility Tests Versus Quantitative MIC Tests, Elsevier Science, New York, 1993.
14. Bryson, V. and Szybalski, W. Microbial selection, Science, 116, 45-51, 1952.
15. Schalkowsky, S. Measures of susceptibility from a spiral gradient of drug concentrations, in Antimicrobial Susceptibility Testing, Poupard, J., Ed., Plenum Press, New York, 1994, 107-120.
16. Bolmstrom, A., Arvidson, S., Ericsson, M., and Karlsson, A. A novel technique for direct quantitation of antimicrobial susceptibility of microorganisms, Presented at the Interscience Conference Antimicrobial Agents and Chemotherapy, Los Angeles, CA, 1988.
17. Washington, J. Current problems in antimicrobial susceptibility testing, Diag. Microbiol. Infect. Dis., 9, 135-138, 1988.
18. Hedges, A. The influence of factors affecting the critical population density of inocula on the determination of bacterial susceptibility to antibiotics by disc diffusion methods, J. Antimicrob. Chemo., 43, 313-316, 1999.
19. CLSI. Performance standards for antimicrobial disk susceptibility tests, approved standard, M2-A8, 8th ed., CLSI, Wayne, PA, 2005.
20. Berke, I. and Tierno, P.M. Comparison of efficacy and cost-effectiveness of BIOMIC VIDEO and Vitek antimicrobial susceptibility test systems for use in the clinical microbiology laboratory, J. Clin. Microbiol., 34, 1980-1984, 1996.
21. Korgenski, E. and Daly, J.A. Evaluation of the BIOMIC video reader system for determining interpretive categories of isolates on the basis of disk diffusion susceptibility results, J. Clin. Microbiol., 36, 302-304, 1998.
22. Jorgensen, J.H., Crawford, S.A., McElmeel, M.L., and Fiebelkorn, K.R. Detection of inducible clindamycin resistance of staphylococci in conjunction with performance of automated broth susceptibility testing, J. Clin. Microbiol., 42, 1800-1802, 2004.
23. Miller, J., Thornsberry, C., and Baker, C.N. Disk diffusion susceptibility test troubleshooting guide, Lab. Med., 15, 183-185, 1984.
24. CDC. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin, Morb. Mortal. Wkly. Rep., 46, 626-635, 1997.
25. Hubert, S.K., Mohammed, J.M., Fridkin, S.K., Gaynes, R.P, McGowan, J.E., Jr., and Tenover, F.C. Glycopeptide-intermediate Staphylococcus aureus: Evaluation of a novel screening method and results of a survey of selected U.S. hospitals, J. Clin. Microbiol., 37, 3590-3593, 1999.
26. Walsh, T.R., Bolmstrom, A., Qwarnstrom, A., Ho, P, Wootton, M., Howe, R.A., MacGowan, A.P., and Diekema, D. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides, J. Clin. Microbiol., 39, 2439-2444, 2001.
27. Hiramatsu, K. Vancomycin resistance in staphylococci, Drug Resist. Updates, 1, 135-150, 1998.
28. CDC. Vancomycin-resistant Staphylococcus aureus - New York, 2004, Morb. Mortal. Wkly. Rep., 53, 322-323, 2004.
29. Walsh, T.R., Bolmstrom, A., Ho, P., Qwarnstrom, A., Wootton, M., Howe, R.A., Bennett, P.M., and MacGowan, A.P. Evaluation of growth conditions in susceptibility testing to discriminate hetero-vancomycin intermediate Staphylococcus aureus (hVISA) and VISAs from methicillin resistant SA (MRSA), Clin. Microbiol. Infect., 6, 84, 2000.
30. Walsh, T.R., Bolmstrom, A., Qwarnstrom, A., and Gales, A. Evaluation of a new Etest for detecting metallo-beta-lactamases in routine clinical testing, J. Clin. Microbiol., 40, 2755-2759, 2002.
31. Espinel-Ingroff, A. A comparison of the Etest with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi, J. Clin. Microbiol., 39, 1360-1367, 2001.
32. Wanger, A. and Mills, K. Etest for susceptibility testing of Mycobacterium tuberculosis and Myco-bacterium avium-intracellulare, Diag. Microbiol. Infect. Dis., 19, 179-181, 1994.
33. Wanger, A. and Mills, K. Testing of Mycobacterium tuberculosis susceptibility to ethambutol, iso-niazid, rifampin and streptomycin by using Etest, J. Clin. Microbiol., 34, 1672-1676, 1996.
34. Wanger, A., Mills, K., Nelson, P., and Rex, J. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates, Antimicrob. Agents Chemother., 39, 2520-2522, 1995.
35. Pankey, G.A. and Ashcraft, D.S. In vitro synergy of ciprofloxacin and gatifloxacin against ciproflox-acin-resistant Pseudomonas aeruginosa, Antimicrob. Agents Chemother., 49, 2959-2964, 2005.
36. Bolmstrom, A. Determinations of minimum bactericidal concentrations, kill curves, and postantibiotic effects with the Etest technology, Diag. Microbiol. Infect. Dis., 19, 187-195, 1994.
37. Mohr, J.F., Wanger, A., and Rex, J.H. Pharmacokinetic/pharmacodynamic modeling can help guide targeted antimicrobial therapy for nosocomial gram-negative infections in critically ill patients, Diag. Microbiol. Infect. Dis., 48, 125-130, 2004.